title: JNK2 mediates TNF-induced cell death in mouse embryonic fibroblasts via regulation of both caspase and cathepsin protease pathways.
abstract: Recent studies strongly suggest an active involvement of the c-Jun N-terminal kinase (JNK) signaling pathway in tumor necrosis factor (TNF)-induced apoptosis. The direct evidence for the role of JNK and its isoforms has been missing and the mechanism of how JNK actually could facilitate this process has remained unclear. In this study, we show that Jnk2-/- primary mouse embryonic fibroblasts (pMEFs) exhibit resistance towards TNF-induced apoptosis as compared to corresponding wild-type and Jnk1-/- pMEFs. JNK2-deficient pMEFs could be resensitized to TNF via retroviral transduction of any of the four different JNK2 splicing variants. Jnk2-/- pMEFs displayed deficient and delayed effector caspase activation as well as impaired cytosolic cystein cathepsin activity: processes that both were needed for efficient TNF-induced apoptosis in pMEFs. Our work demonstrates that JNK has a central role in the promotion of TNF-induced apoptosis in pMEFs, and that the JNK2 isoform can regulate both mitochondrial and lysosomal death pathways in these cells.
authors.affiliation: Apoptosis Laboratory, Danish Cancer Society, Strandboulevarden 49, Copenhagen, Denmark. tk@cancer.dk
authors.forename: N
authors.initials: N
authors.lastname: Dietrich
authors.forename: J
authors.initials: J
authors.lastname: Thastrup
authors.forename: C
authors.initials: C
authors.lastname: Holmberg
authors.forename: M
authors.initials: M
authors.lastname: Gyrd-Hansen
authors.forename: N
authors.initials: N
authors.lastname: Fehrenbacher
authors.forename: U
authors.initials: U
authors.lastname: Lademann
authors.forename: M
authors.initials: M
authors.lastname: Lerdrup
authors.forename: T
authors.initials: T
authors.lastname: Herdegen
authors.forename: M
authors.initials: M
authors.lastname: Jäättelä
authors.forename: T
authors.initials: T
authors.lastname: Kallunki
mesh_terms: D017398:Alternative Splicing; D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D020169:Caspases / Q000032:analysis / Q000378:metabolism*; D002401:Cathepsin B / Q000378:metabolism; D002403:Cathepsins / Q000032:analysis / Q000378:metabolism*; D002470:Cell Survival; D045304:Cytochromes c / Q000378:metabolism; D003600:Cytosol / Q000201:enzymology; D004247:DNA / Q000378:metabolism; D004789:Enzyme Activation / Q000187:drug effects; D005333:Fetus / Q000166:cytology / Q000378:metabolism; D005347:Fibroblasts / Q000166:cytology / Q000378:metabolism*; D017353:Gene Deletion; D014644:Genetic Variation; D008247:Lysosomes / Q000378:metabolism; D051379:Mice; D018613:Microscopy, Confocal; D008928:Mitochondria / Q000378:metabolism; D008954:Models, Biological; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D016755:Proto-Oncogene Proteins c-jun / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D012190:Retroviridae / Q000235:genetics; D013194:Staining and Labeling; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
chemical_list: D020033:Protein Isoforms; D016755:Proto-Oncogene Proteins c-jun; D014409:Tumor Necrosis Factor-alpha; D045304:Cytochromes c; D004247:DNA; D002403:Cathepsins; D020169:Caspases; D002401:Cathepsin B